Back to Vet Dispatch

Dogs & Cats

Metoclopramide in Dogs and Cats: Antiemetic and Prokinetic Guide

Aug 2, 2026 6 min read

Bottom line

Metoclopramide is an inexpensive, extralabel dual-action GI drug: peripherally it is an upper-GI prokinetic (5-HT4 agonism plus cholinergic sensitization that raises lower esophageal sphincter tone and speeds gastric emptying), and centrally it is a dopamine (D2) antiemetic at the chemoreceptor trigger zone. [1][2] Its enduring niche is prokinesis for reflux, delayed gastric emptying, and post-operative ileus, because it is a weaker, less selective antiemetic than maropitant or ondansetron and is unreliable for motion sickness. Before dosing, exclude GI obstruction or perforation. [2]

From reading to clinical reasoning

Pressure-test the decisions behind this article

Open Clinical Desk with the public topic prefilled. Add patient context only after you are inside the secure vet workspace.

metoclopramide dose dogs cats

Patient details stay inside the authenticated workspace.

Drug facts

Metoclopramide is a substituted benzamide, used extralabel in veterinary medicine (human Reglan) and available as tablets, oral solution, and injectable. It is "a central dopaminergic receptor antagonist and peripheral 5-HT3 receptor antagonist and 5-HT4 receptor agonist with GI and CNS effects." [1] Antiemetic activity is dose-dependent: at lower doses it "inhibits dopaminergic transmission in the CNS," and at higher doses it "inhibits serotonergic receptors in the CRTZ." [2] Peripherally it "increases both acetylcholine release from neurons and cholinergic receptor sensitivity to acetylcholine," which "stimulates and coordinates esophageal, gastric, pyloric, and duodenal motor activity," "increases lower esophageal sphincter tone," and "speeds gastric emptying of liquids; however, it may slow the emptying of solids." [1] Critically for prokinetic planning, it "has little or no effect on colonic motility" — it is an upper-GI drug only. [1] Oral bioavailability is limited (roughly 50%) because of a significant first-pass effect. [2]

Dosing

Intermittent dosing (first-line for ward and outpatient use). The Merck Veterinary Manual lists the prokinetic dose for dogs and cats as "0.2–0.5 mg/kg, PO or SC, q 8 h" [1] and the antiemetic dose as "0.1–0.5 mg/kg, IM, SC, or PO, q 6–8 h." [2] Because of the short duration of action, give it three to four times daily; for prokinesis, administer roughly 30 minutes before feeding.

Constant-rate infusion (refractory vomiting or ileus). Merck lists "0.01–0.02 mg/kg/h, IV infusion." [1] For hospitalized ileus, Today's Veterinary Practice describes "a 0.5 mg/kg IV bolus followed by a 2 mg/kg/day CRI," titrated up to "8 mg/kg/day if needed based on persistence of the ileus," and notes that perioperatively "much higher rates may be needed (1 mg/kg bolus followed by 1 mg/kg/h in the perianesthetic period)." [3] (For orientation, 0.01–0.02 mg/kg/h equals roughly 0.24–0.48 mg/kg/day, the low end of the reported CRI range.)

Dog vs cat. The mg/kg dose is the same across species, but efficacy is not: metoclopramide is a "useful antiemetic for dogs" yet is less effective in cats because dopamine D2 receptors at the chemoreceptor trigger zone "are not very important in mediating humoral emesis in cats." [2]

Higher-risk patients. Extrapyramidal and other CNS signs are more likely at higher doses, with prolonged use, and in patients with reduced drug clearance; lower the dose or lengthen the dosing interval if they appear.

Indications

Reach for metoclopramide primarily as an upper-GI prokinetic: gastroesophageal reflux and regurgitation from delayed gastric emptying, gastroparesis, and postoperative or functional ileus, where its acceleration of gastric emptying and increased lower esophageal sphincter tone are the therapeutic goal. [1] For antiemesis, the Merck Veterinary Manual lists control of "emesis induced by chemotherapy, nausea and vomiting associated with delayed gastric emptying, reflux gastritis, and viral enteritis." [2] It is one of the few readily available prokinetics, whereas newer NK-1 antiemetics such as maropitant "have shown no effect on GI motility." [3] When treating reflux, pair it with an acid suppressant such as omeprazole; for pure antiemesis, maropitant or ondansetron is usually the better choice, and inappetent cats may also need an appetite stimulant such as mirtazapine.

Contraindications & cautions

Mechanical GI disease is the key contraindication. Because it drives motility against a fixed obstruction, "GI obstruction, such as intussusception in puppies with parvoviral enteritis, must be excluded before treatment," [1] and it "should not be administered if a GI obstruction or perforation is suspected." [2] It also "should not be used in animals with GI obstruction, perforation, or hemorrhage," "should not be used in animals with a history of seizures, as it may lower the seizure threshold," and "should not be used in animals with pheochromocytoma," where it may precipitate a hypertensive crisis. [4] Use caution alongside other CNS-active drugs: metoclopramide "may increase the CNS-depressant effects of phenothiazine tranquilizers, sedatives, narcotics, barbiturates, antihistamines, and anesthetic agents," and its extrapyramidal effects are potentiated by phenothiazines and butyrophenones. [4]

Adverse effects

The signature toxicity is central and extrapyramidal. Merck describes "extrapyramidal signs, which include involuntary muscle spasms, motor restlessness, and inappropriate aggression," arising from dopaminergic receptor antagonism in the striatum, most often at high doses or with rapid IV administration. [1] These "can be counteracted with an antihistamine such as diphenhydramine." [2] Cats in particular "may experience hyperactivity or disorientation." [4] Signs are dose-related and reversible, resolving within days of dose reduction or discontinuation; risk rises with higher doses, in cats, and with renal impairment. [4]

Metoclopramide vs maropitant/ondansetron

As a pure antiemetic, metoclopramide is the weakest and least selective of the three. Maropitant (an NK-1 antagonist) and ondansetron (a 5-HT3 antagonist) block emesis broadly and potently, whereas metoclopramide's dopamine-driven antiemesis is unreliable in cats — D2 receptors "are not very important in mediating humoral emesis in cats" — and it is ineffective for motion sickness, for which maropitant is the drug of choice. [2] What metoclopramide offers that the other two do not is prokinesis: maropitant and ondansetron have no meaningful effect on gastric emptying, and maropitant specifically "have shown no effect on GI motility." [3] Practical framing: choose maropitant or ondansetron when the goal is stopping vomiting, and metoclopramide (or a CRI) when the goal is moving the upper GI tract, such as reflux control or ileus. The roles are complementary and the drugs are frequently combined.

Frequently Asked Questions

What is the metoclopramide dose for a dog? The Merck Veterinary Manual lists 0.1–0.5 mg/kg IM, SC, or PO every 6–8 hours as an antiemetic, and 0.2–0.5 mg/kg PO or SC every 8 hours as a prokinetic. Give it about 30 minutes before meals when the goal is prokinesis.

What is the metoclopramide CRI rate? The Merck Veterinary Manual lists a continuous IV infusion of 0.01–0.02 mg/kg/h. For hospitalized ileus, Today's Veterinary Practice describes a 0.5 mg/kg IV loading bolus followed by a 2 mg/kg/day CRI, titrated up to 8 mg/kg/day based on persistence of the ileus, with even higher perioperative rates (a 1 mg/kg bolus then 1 mg/kg/h).

What are the contraindications for metoclopramide? The Merck Veterinary Manual flags GI obstruction and perforation as contraindications; additional cautions include GI hemorrhage, a history of seizures (it lowers the seizure threshold), and pheochromocytoma, where it can trigger a hypertensive crisis.

Metoclopramide vs maropitant — which is better? For stopping vomiting, maropitant (an NK-1 antagonist) is broader and more potent; the Merck Veterinary Manual notes metoclopramide is less effective in cats and useless for motion sickness. Metoclopramide's advantage, per Today's Veterinary Practice, is prokinesis — maropitant has no effect on GI motility.

What are metoclopramide extrapyramidal signs? The Merck Veterinary Manual describes involuntary muscle spasms, motor restlessness, and inappropriate aggression caused by dopamine antagonism in the striatum, usually at high doses or with rapid IV use. They are reversible and can be counteracted with an antihistamine such as diphenhydramine.

Is metoclopramide effective in cats? Less so than in dogs. The Merck Veterinary Manual explains that D2 receptors at the chemoreceptor trigger zone are not very important for humoral emesis in cats, and Wedgewood Pharmacy notes cats may show hyperactivity or disorientation, so the drug is used more for prokinesis than antiemesis in this species.

Can metoclopramide be used for motion sickness or chemotherapy vomiting? Metoclopramide is ineffective for motion sickness — maropitant is preferred — and it is only modestly helpful for chemotherapy emesis, where ondansetron or maropitant are the better choices.

How should metoclopramide be timed with food? For prokinetic use, give it roughly 30 minutes before feeding so peak effect coincides with the meal. Oral bioavailability is only about 50% because of first-pass metabolism, per the Merck Veterinary Manual, which is why injectable and CRI routes are used in hospitalized patients.

References

  1. Merck Veterinary Manual - Gastrointestinal Prokinetic Drugs Used in Monogastric Animals (2024)
  2. Merck Veterinary Manual - Drugs Used to Control or Stimulate Vomiting in Monogastric Animals (2024)
  3. Today's Veterinary Practice - Management of Gastrointestinal Hypomotility in the Hospitalized Patient (2021)
  4. Wedgewood Pharmacy - Metoclopramide for Dogs, Cats, and Horses (2024)

More clinical updates

Dogs & CatsAug 7, 2026

Cisapride in cats and dogs: regulatory status, dosing, and cardiac safety

Cisapride has the broadest prokinetic reach of the drugs in common use, which is why it anchors medical management of feline constipation and early megacolon. It is also an unapproved, compounded-only drug with no controlled clinical trial in cats, a fifteenfold spread across published dose recommendations, and a hERG-mediated cardiac liability characterised in cats and dogs only at grossly supratherapeutic doses. This hub separates trial evidence from expert recommendation, quotes every dose figure from the source that printed it, and sets out where cisapride stops working — a failure of enteric nerves, not of muscle — and surgery begins.

Read →
Dogs & CatsAug 6, 2026

Sucralfate in Dogs and Cats: Dosing, Timing, and What the Evidence Supports

Sucralfate is a locally acting mucosal barrier agent that needs acid to work, not an acid suppressant. What the 2018 ACVIM consensus actually recommends, the PPI co-administration question, the quantified 2-hour drug-separation data in dogs, and dosing for both species.

Read →
Dogs & CatsAug 4, 2026

Metronidazole in Dogs and Cats: A Clinical Evidence Review

A clinical reference on metronidazole in dogs and cats: mechanism and spectrum, the randomised trials on acute diarrhoea, measured microbiome effects, the neurotoxicity dose-duration relationship, verbatim dosing, feline cautions, and stewardship-aligned alternatives.

Read →
Dogs & CatsAug 4, 2026

Famotidine in Dogs and Cats: A Clinical Reference

Famotidine works, modestly and briefly. A practising clinician's reference on where it sits versus omeprazole, the tachyphylaxis data in dogs and cats, the indications the evidence does not support, and when a PPI or nothing at all is the better call.

Read →